QTTB vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

QTTB

37.4
AI Score
VS
QTTB Wins

JBIO

32.5
AI Score

Investment Advisor Scores

QTTB

37score
Recommendation
AVOID NEW MONEY

JBIO

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric QTTB JBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 37.4/100 32.5/100 QTTB
Profit Margin 60.0% 0.0% QTTB
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

QTTB 1M: +13.8% · 3M: -40.3% JBIO 1M: +24.9% · 3M: -29.6%

Current Technical Phase

QTTB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.8 · Price: $9.18

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 64.1 · Price: $16.76

Fundamentals Snapshot

Metric QTTB JBIO
Market Cap — —
Forward P/E -4.3 -6.2
Trailing P/E 2.6 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.7% —
Operating Margin 0.3% 0.0%
EPS 3.60 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, QTTB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.